Advanced Nucleic Acid Therapeutics and Next-Generation Molecular Design

In parallel, we engineer innovative nucleic acid–based therapeutics designed to achieve substantial improvements in efficacy, durability, and target specificity. Our work focuses on the rational configuration of molecular payloads and delivery architectures that enhance intracellular performance, prolong therapeutic activity, and reduce unintended effects. By integrating advances in molecular configuration, chemical modification, and delivery optimization, we aim to establish a new class of nucleic acid therapeutics with improved safety profiles and sustained therapeutic benefit.